Singapore markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.6500+0.0100 (+0.61%)
At close: 04:00PM EDT
1.6100 -0.04 (-2.42%)
After hours: 04:17PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-1.43-1.14-4.93-4.32
Low estimate-2.04-1.66-7.15-6.96
High estimate-0.83-0.62-2.71-1.69
Year ago EPS-6.6-7.35-26.75-4.93
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1121
Avg. Estimate30k30k60k100k
Low estimate30k30kN/A100k
High estimate30k30k120k100k
Year ago sales373k16k420k60k
Sales growth (year/est)-92.00%87.50%-85.70%66.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-7.55-5.45-5.89-4.74
Actual EPS-6.6-7.35-6.23-2.27
Difference0.95-1.9-0.342.47
Surprise %12.60%-34.90%-5.80%52.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.43-1.14-4.93-4.32
7 days ago-1.43-1.14-4.93-4.32
30 days ago-1.43-1.14-4.93-4.32
60 days ago-1.69-1.34-6.32-5.54
90 days ago-3.44-3.2-13.38-24.37
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCYCCIndustrySector(s)S&P 500
Current qtr.78.30%N/AN/AN/A
Next qtr.84.50%N/AN/AN/A
Current year81.60%N/AN/AN/A
Next year12.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A